Therapeutic targets modulation, inhibition, and activation /
I tiakina i:
Kaituhi rangatōpū: | ebrary, Inc |
---|---|
Ētahi atu kaituhi: | Botana, Luis M., Loza, Mabel |
Hōputu: | Tāhiko īPukapuka |
Reo: | Ingarihi |
I whakaputaina: |
Hoboken, N.J. :
John Wiley & Sons,
c2012.
|
Ngā marau: | |
Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
Therapeutic targets modulation, inhibition, and activation /
I whakaputaina: (2012)
I whakaputaina: (2012)
ADME-enabling technologies for drug design and development
I whakaputaina: (2012)
I whakaputaina: (2012)
ADME-enabling technologies for drug design and development
I whakaputaina: (2012)
I whakaputaina: (2012)
Development of therapeutic agents handbook
I whakaputaina: (2012)
I whakaputaina: (2012)
Development of therapeutic agents handbook
I whakaputaina: (2012)
I whakaputaina: (2012)
The agile approach to adaptive research optimizing efficiency in clinical development /
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
The agile approach to adaptive research optimizing efficiency in clinical development /
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
Pharmaceutical industry innovation and developments /
I whakaputaina: (2011)
I whakaputaina: (2011)
Pharmaceutical industry innovation and developments /
I whakaputaina: (2011)
I whakaputaina: (2011)
Outsourcing clinical development strategies for working with CROs and other partners /
I whakaputaina: (2006)
I whakaputaina: (2006)
Outsourcing clinical development strategies for working with CROs and other partners /
I whakaputaina: (2006)
I whakaputaina: (2006)
Quality assurance of pharmaceuticals a compendium of guidelines and related materials. Volume 2, Good manufacturing practices and inspection.
I whakaputaina: (2007)
I whakaputaina: (2007)
Quality assurance of pharmaceuticals a compendium of guidelines and related materials. Volume 2, Good manufacturing practices and inspection.
I whakaputaina: (2007)
I whakaputaina: (2007)
Drugs : from discovery to approval /
mā: Ng, Rick
I whakaputaina: (2015)
mā: Ng, Rick
I whakaputaina: (2015)
Drugs : from discovery to approval /
mā: Ng, Rick
I whakaputaina: (2015)
mā: Ng, Rick
I whakaputaina: (2015)
Gene family targeted molecular design
I whakaputaina: (2009)
I whakaputaina: (2009)
Gene family targeted molecular design
I whakaputaina: (2009)
I whakaputaina: (2009)
Drug discovery and design medical aspects /
I whakaputaina: (2002)
I whakaputaina: (2002)
Drug discovery and design medical aspects /
I whakaputaina: (2002)
I whakaputaina: (2002)
Drug discovery practices, processes, and perspectives /
I whakaputaina: (2013)
I whakaputaina: (2013)
Drug discovery practices, processes, and perspectives /
I whakaputaina: (2013)
I whakaputaina: (2013)
Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
I whakaputaina: (2012)
I whakaputaina: (2012)
Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
I whakaputaina: (2012)
I whakaputaina: (2012)
Applications of microdialysis in pharmaceutical science
I whakaputaina: (2011)
I whakaputaina: (2011)
Applications of microdialysis in pharmaceutical science
I whakaputaina: (2011)
I whakaputaina: (2011)
Drug discovery handbook
I whakaputaina: (2005)
I whakaputaina: (2005)
Drug discovery handbook
I whakaputaina: (2005)
I whakaputaina: (2005)
Retrometabolic drug design and targeting
mā: Bodor, Nicholas
I whakaputaina: (2012)
mā: Bodor, Nicholas
I whakaputaina: (2012)
Retrometabolic drug design and targeting
mā: Bodor, Nicholas
I whakaputaina: (2012)
mā: Bodor, Nicholas
I whakaputaina: (2012)
Human drug targets : a compendium for pharmaceutical discovery /
mā: Zanders, Edward D.
I whakaputaina: (2016)
mā: Zanders, Edward D.
I whakaputaina: (2016)
Human drug targets : a compendium for pharmaceutical discovery /
mā: Zanders, Edward D.
I whakaputaina: (2016)
mā: Zanders, Edward D.
I whakaputaina: (2016)
Target validation in drug discovery
I whakaputaina: (2006)
I whakaputaina: (2006)
Target validation in drug discovery
I whakaputaina: (2006)
I whakaputaina: (2006)
Statistical thinking for non-statisticians in drug regulation /
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)
Statistical thinking for non-statisticians in drug regulation /
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)
Pharmacokinetics and metabolism in drug design
I whakaputaina: (2012)
I whakaputaina: (2012)
Pharmacokinetics and metabolism in drug design
I whakaputaina: (2012)
I whakaputaina: (2012)
Post-genomic approaches in drug and vaccine development /
I whakaputaina: (2015)
I whakaputaina: (2015)
Post-genomic approaches in drug and vaccine development /
I whakaputaina: (2015)
I whakaputaina: (2015)
Pharmacogenetics opportunities and challenges for health innovation.
I whakaputaina: (2009)
I whakaputaina: (2009)
Ngā tūemi rite
-
Therapeutic targets modulation, inhibition, and activation /
I whakaputaina: (2012) -
ADME-enabling technologies for drug design and development
I whakaputaina: (2012) -
ADME-enabling technologies for drug design and development
I whakaputaina: (2012) -
Development of therapeutic agents handbook
I whakaputaina: (2012) -
Development of therapeutic agents handbook
I whakaputaina: (2012)